Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice

Published:2021-01-11 Issue:3 Volume:6 Page:277-288
ISSN:2058-5276
Container-title:Nature Microbiology
language:en
Short-container-title:Nat Microbiol

Author:

Lee Se-Hoon,Cho Sung-Yup,Yoon Youngmin,Park Changho,Sohn Jinyoung,Jeong Jin-Ju,Jeon Bu-Nam,Jang Mongjoo,An Choa,Lee Suro,Kim Yun Yeon,Kim Gihyeon,Kim Sujeong,Kim Yunjae,Lee Gwang Bin,Lee Eun Ju,Kim Sang Gyun,Kim Hong Sook,Kim Yeongmin,Kim Hyun,Yang Hyun-Suk,Kim Sarang,Kim Seonggon,Chung Hayung,Moon Myeong Hee^ORCID,Nam Myung Hee,Kwon Jee Young,Won Sungho,Park Joon-Suk,Weinstock George M.^ORCID,Lee Charles,Yoon Kyoung Wan,Park Hansoo^ORCID

Funder

Ministry of Trade, Industry and Energy

National Research Foundation of Korea

Ewha Womans University

Xi'an Jiaotong University

Ministry of Health and Welfare

National Cancer Center

Gwangju Institute of Science and Technology

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Microbiology (medical),Genetics,Applied Microbiology and Biotechnology,Immunology,Microbiology

Link

http://www.nature.com/articles/s41564-020-00831-6.pdf

Reference59 articles.

1. Viaud, S. et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 342, 971–976 (2013).

2. Daillère, R. et al. Enterococcus hirae and Barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects. Immunity 45, 931–943 (2016).

3. Iida, N. et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 342, 967–970 (2013).

4. Sivan, A. et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350, 1084–1089 (2015).

5. Gopalakrishnan, V. et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359, 97–103 (2018).

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of resistance to immunotherapy;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025

2. Dual metabolic modification of tumor-targeted bacteria for synergistic chemo-photodynamic therapy and immunotherapy;Chemical Engineering Journal;2024-10

3. From bench to bedside: an interdisciplinary journey through the gut-lung axis with insights into lung cancer and immunotherapy;Frontiers in Immunology;2024-09-05

4. A role of gut microbiota metabolites in HLA-E and NKG2 blockage immunotherapy against tumors: new insights for clinical application;Frontiers in Immunology;2024-08-20

5. Strategies to enhance the therapeutic efficacy of anti-PD-1 antibody, anti-PD-L1 antibody and anti-CTLA-4 antibody in cancer therapy;Journal of Translational Medicine;2024-08-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3